P

Inventor

WU YONG-JIN

US45 patents
⚠️ This page may combine multiple inventors who share the name “WU YONG-JIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

22 patents
US7045551B2May 16, 2006

1-aryl-2-hydroxyethyl amides as potassium channel openers

BRISTOL MYERS SQUIBB CO35 citations92
US7098203B2Aug 29, 2006

Homopiperidine derivatives as NK-1 antagonists

BRISTOL MYERS SQUIBB CO13 citations84
US7138423B2Nov 21, 2006

Arylpyrrolidine derivatives as NK-1 /SSRI antagonists

BRISTOL MYERS SQUIBB CO10 citations74
US6933308B2Aug 23, 2005

Aminoalkyl thiazole derivatives as KCNQ modulators

BRISTOL MYERS SQUIBB CO11 citations74
US6900210B2May 31, 2005

Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers

BRISTOL MYERS SQUIBB CO7 citations74
US6831080B2Dec 14, 2004

Cinnamide derivatives as KCNQ potassium channel modulators

BRISTOL MYERS SQUIBB CO11 citations71
US11767322B2Sep 26, 2023

Triazolopyridinyl compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO3 citations70
US7087609B2Aug 8, 2006

3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers

BRISTOL MYERS SQUIBB CO5 citations63
US7494986B2Feb 24, 2009

Cycloalkylamine derivatives as NK-1/SSRI antagonists

BRISTOL MYERS SQUIBB CO4 citations62
US7276631B2Oct 2, 2007

Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists

BRISTOL MYERS SQUIBB CO4 citations62
US7144881B2Dec 5, 2006

Arylcyclopropylcarboxylic amides as potassium channel openers

BRISTOL MYERS SQUIBB CO5 citations62
US7135472B2Nov 14, 2006

3-Heterocyclic benzylamide derivatives as potassium channel openers

BRISTOL MYERS SQUIBB CO4 citations62
US12110290B2Oct 8, 2024

Triazolopyridinyl compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations61
US8349880B2Jan 8, 2013

Bicyclic compounds for the reduction of beta-amyloid production

BRISTOL MYERS SQUIBB CO4 citations61
US7390925B2Jun 24, 2008

Oxime-containing acyl guanidines as beta-secretase inhibitors

BRISTOL MYERS SQUIBB CO5 citations61
US6875771B2Apr 5, 2005

Pyridopyrimidine derivatives as 5-HT6 antagonists

BRISTOL MYERS SQUIBB CO3 citations59
US7476764B2Jan 13, 2009

Phenylcarboxyamides as beta-secretase inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US11618753B2Apr 4, 2023

Aminopyrrolotriazines as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US7678784B2Mar 16, 2010

Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors

BRISTOL MYERS SQUIBB CO0 citations50
US7273866B2Sep 25, 2007

2-aryl thiazole derivatives as KCNQ modulators

BRISTOL MYERS SQUIBB CO0 citations41
US10836758B2Nov 17, 2020

Acyl sulfonamide NaV1.7 inhibitors

BRISTOL MYERS SQUIBB CO0 citations40
US9475784B2Oct 25, 2016

4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production

BRISTOL MYERS SQUIBB CO0 citations40

PFIZER

13 patents

BOY KENNETH M

4 patents

UNIV VANDERBILT

2 patents

WU YONG-JIN

1 patent

TPK ADVANCED SOLUTIONS INC

1 patent

BRISTOL MEYERS SQUIBB CO

1 patent

THOMPSON III LORIN A

1 patent